Clinical and pathological heterogeneity of cervical intraepithelial neoplasia grade 3

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Yang, Hannah P ^a   Zuna, Rosemary E ^b   Schiffman, Mark ^a   Walker, Joan L ^b   Sherman, Mark E ^a   Landrum, Lisa M ^b   Moxley, Katherine ^b   Gold, Michael A ^c   Dunn, S Terence ^b   Allen, Richard A ^b   Zhang, Roy ^b   Long, Rodney ^d   Wang, Sophia S ^e   Wentzensen, Nicolas ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER GRADING; CANCER SCREENING; CONTROLLED STUDY; ELECTROSURGERY; EXCISION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; POPULATION RESEARCH; PREDICTION; SEXUAL BEHAVIOR; TUMOR VOLUME; UNITED STATES; UTERINE CERVIX CARCINOMA IN SITU; ADOLESCENT; AGE DISTRIBUTION; COLPOSCOPY; GENETIC HETEROGENEITY; MASS SCREENING; MIDDLE AGED; PATHOLOGY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX TUMOR;

HUMAN PAPILLOMAVIRUS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; ELECTROSURGERY; FEMALE; GENETIC HETEROGENEITY; HUMANS; MASS SCREENING; MIDDLE AGED; NEOPLASM GRADING; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEXUAL BEHAVIOR; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84855830664     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029051     Document Type: Article

References (27)

1. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S, (2007) Human papillomavirus and cervical cancer. Lancet 370: 890-907.
2. Schiffman M, Wentzensen N, (2010) From human papillomavirus to cervical cancer. Obstet Gynecol 116: 177-185.
3. Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, et al. (2007) 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet Gynecol 197: 340-345.
4. Mitchell MF, Tortolero-Luna G, Wright T, Sarkar A, Richards-Kortum R, et al. (1996) Cervical human papillomavirus infection and intraepithelial neoplasia: a review. J Natl Cancer Inst Monogr pp. 17-25.
5. McCredie MR, Sharples KJ, Paul C, Baranyai J, Medley G, et al. (2008) Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncology 9: 425-434.
6. Schiffman M, Rodriguez AC, (2008) Heterogeneity in CIN3 diagnosis. Lancet Oncology 9: 404-406.
7. Cardenas-Turanzas M, Follen M, Benedet JL, Cantor SB, (2005) See-and-treat strategy for diagnosis and management of cervical squamous intraepithelial lesions. Lancet Oncol 6: 43-50.
8. Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, et al. (2006) Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet 367: 489-498.
9. Tidbury P, Singer A, Jenkins D, (1992) CIN 3: the role of lesion size in invasion. Br J Obstet Gynaecol 99: 583-586.
10. Sherman ME, Wang SS, Tarone R, Rich L, Schiffman M, (2003) Histopathologic extent of cervical intraepithelial neoplasia 3 lesions in the atypical squamous cells of undetermined significance low-grade squamous intraepithelial lesion triage study: implications for subject safety and lead-time bias. Cancer Epidemiology, Biomarkers and Prevention 12: 372-379.
11. Pretorius RG, Zhang X, Belinson JL, Zhang WH, Ren SD, et al. (2006) Distribution of cervical intraepithelial neoplasia 2, 3 and cancer on the uterine cervix. J Low Genit Tract Dis 10: 45-50.
12. Wang SS, Zuna RE, Wentzensen N, Dunn ST, Sherman ME, et al. (2009) Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants. Cancer Epidemiol Biomarkers Prev 18: 113-120.
13. Wentzensen N, Schiffman M, Dunn T, Zuna RE, Gold MA, et al. (2009) Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int J Cancer 125: 2151-2158.
14. Richart RM, (1965) Colpomicroscopic Studies of the Distribution of Dysplasia and Carcinoma in Situ on the Exposed Portion of the Human Uterine Cervix. Cancer 18: 950-954.
15. Heatley M, (1995) Distribution of cervical intraepithelial neoplasia: are hysterectomy specimens sampled appropriately? J Clin Pathol 48: 323-324.
16. Allard JE, Rodriguez M, Rocca M, Parker MF, (2005) Biopsy site selection during colposcopy and distribution of cervical intraepithelial neoplasia. J Low Genit Tract Dis 9: 36-39.
17. Guido RS, Jeronimo J, Schiffman M, Solomon D, (2005) The distribution of neoplasia arising on the cervix: results from the ALTS trial. Am J Obstet Gynecol 193: 1331-1337.
18. Lurie S, Eliaz M, Boaz M, Levy T, Golan A, et al. (2007) Distribution of cervical intraepithelial neoplasia across the cervix is random. Am J Obstet Gynecol 196: 125 e121-123.
19. Massad LS, Halperin CJ, Bitterman P, (1996) Correlation between colposcopically directed biopsy and cervical loop excision. Gynecol Oncol 60: 400-403.
20. Szurkus DC, Harrison TA, (2003) Loop excision for high-grade squamous intraepithelial lesion on cytology: correlation with colposcopic and histologic findings. Am J Obstet Gynecol 188: 1180-1182.
21. Wheeler CM, (2008) Natural history of human papillomavirus infections, cytologic and histologic abnormalities, and cancer. Obstet Gynecol Clin North Am 35: 519-536; vii.
22. Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, et al. (2005) Carcinogenicity of human papillomaviruses. Lancet Oncol 6: 204.
23. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, et al. (2007) Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 121: 621-632.
24. Vinokurova S, Wentzensen N, Kraus I, Klaes R, Driesch C, et al. (2008) Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. Cancer Res 68: 307-313.
25. Porras C, Rodriguez AC, Hildesheim A, Herrero R, Gonzalez P, et al. (2009) Human papillomavirus types by age in cervical cancer precursors: predominance of human papillomavirus 16 in young women. Cancer Epidemiol Biomarkers Prev 18: 863-865.
26. Wheeler CM, Hunt WC, Joste NE, Key CR, Quint WG, et al. (2009) Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States. J Natl Cancer Inst 101: 475-487.
27. Cuzick J, Arbyn M, Sankaranarayanan R, Tsu V, Ronco G, et al. (2008) Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine 26 Suppl 10: K29-41.